e.g. mhealth
Search Results (1 to 4 of 4 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 Journal of Medical Internet Research
- 1 JMIR Cardio
- 1 JMIR mHealth and uHealth
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Digital Biomarker–Based Interventions: Systematic Review of Systematic Reviews
DBMs are “objective, measurable, physiological, and behavioral parameters collected using wearable, portable, implantable, or digestible digital devices” [2]. In this research, we defined DBMs as either behavioral/physiological data or the digital devices used to collect these data. Wearable, implantable, or digestible medical devices or sensors that generate physiologic or behavioral data were considered digital biomarkers (eg, fitness trackers and defibrillators).
J Med Internet Res 2022;24(12):e41042
Download Citation: END BibTex RIS
Digital Biomarker–Based Studies: Scoping Review of Systematic Reviews
A new notion, digital biomarkers, has emerged in medicine: “objective, quantifiable, physiological and behavioral measures collected using digital devices that are portable, wearable, implantable or digestible” [4]. In addition to their clinical value, digital biomarkers enable new health care value chains [5].
JMIR Mhealth Uhealth 2022;10(10):e35722
Download Citation: END BibTex RIS
In this context, the patients’ perspective on the use and acceptance of these innovative implantable technologies has been poorly studied.
We here report our experience with implantation of a new intracardiac device designed to monitor the left intra-atrial pressure (LAP) of patients with chronic HF through an internet-based information system. The applicability and effectiveness of this technology are currently under evaluation in a multicenter prospective trial (V-LAP study).
JMIR Cardio 2021;5(1):e21055
Download Citation: END BibTex RIS
Cardiac resynchronization therapy (CRT) devices and implantable cardioverter-defibrillators (ICDs) are guideline-recommended treatments for heart failure with reduced ejection fraction, left bundle branch block, very wide QRS complex (>150 ms), or sudden cardiac death [1,2]. The use of these cardiovascular implantable electronic devices (CIEDs) is rapidly increasing with 51,274 and 85,289 patients, respectively, receiving a CRT or ICD device in Europe in 2013 [3].
J Med Internet Res 2017;19(11):e393
Download Citation: END BibTex RIS